PEEL-224
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PEEL-224, covering 2025-06-17 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas [Phase 1, Phase 2]